Occupational Community-Acquired Pneumonia in a Fitter-Splicer with a Significant Smoking History: A Case Report and Expanded Review of the Literature

Occupational Community-Acquired Pneumonia in a Fitter-Splicer with a Significant Smoking History: A Case Report and Expanded Review of the Literature

Authors

  • Anthony Suranta Surbakti BTR-BKP Primary Clinic, Southwest Maluku Regency, Maluku Province, Indonesia
  • Agus Juanda BTR-BKP Primary Clinic, Southwest Maluku Regency, Maluku Province, Indonesia

Keywords:

Community-Acquired Pneumonia, Occupational Health, Pneumoconiosis, Fitter, Welding, Smoking, Risk Factors

Abstract

Introduction: Community-acquired pneumonia (CAP) is a primary driver of global morbidity and mortality, with its incidence heavily influenced by host and environmental factors. While the roles of age, comorbidities, and smoking are well-established, the contribution of occupational exposures—particularly the complex and synergistic hazards faced by industrial workers—remains a critical and often under-appreciated component of risk assessment. This report presents an in-depth analysis of a fitter-splicer, a profession with a unique combination of respiratory hazards, who developed CAP, providing a platform to explore the intricate relationship between workplace environment, lifestyle factors, and infectious disease susceptibility.

Case Illustration: A 50-year-old male with a 30-pack-year smoking history presented with a one-week history of a worsening productive cough, persistent fever, right-sided pleuritic chest pain, and a significant episode of hemoptysis. Physical examination revealed focal findings over the right lower lung, including decreased tactile fremitus, diminished breath sounds, and localized rhonchi, indicative of parenchymal consolidation. Laboratory investigations showed marked neutrophilic leukocytosis and a profoundly elevated C-reactive protein level (165 mg/L). A chest radiograph confirmed dense consolidation in the right lower lobe, consistent with lobar pneumonia. Despite being stratified as low severity by both the CURB-65 and Pneumonia Severity Index (PSI) scores, he was hospitalized due to his clinical presentation and occupational context. He was managed with a dual antibiotic regimen of intravenous ceftriaxone and oral levofloxacin. The patient demonstrated a favorable clinical response and was discharged after a nine-day hospital stay.

Discussion: This case serves as a paradigm for the critical interplay between a patient's multifaceted occupational exposures and his extensive smoking history. The role of a "fitter-splicer" is deconstructed to reveal a dual-threat exposure profile: inhalation of metal fumes and inorganic dusts (e.g., silica) from fitting, grinding, and welding, combined with exposure to chemical vapors and organic dusts from conveyor belt splicing and vulcanization processes. These exposures are known to synergistically impair pulmonary immune defenses. This chronic occupational insult, compounded by decades of smoking-induced lung damage, created a state of profound susceptibility to infection. This decision represents a significant deviation from current evidence-based guidelines, which now strongly recommend against their routine use in non-severe CAP, reserving them for patients with severe disease characterized by a hyperinflammatory state. The differential diagnoses of tuberculosis and underlying malignancy are explored in detail, emphasizing the necessity of post-discharge radiological follow-up in this high-risk patient.

Conclusion: This case underscores the clinical imperative to obtain a detailed occupational and environmental history in all patients presenting with CAP. It vividly demonstrates how combined industrial exposures and smoking can dramatically amplify pneumonia risk by overwhelming the lung's clearance and immune mechanisms. Furthermore, it highlights the urgent need for robust preventive strategies in high-risk occupations, including the stringent implementation of the hierarchy of controls in the workplace, targeted and accessible smoking cessation programs, and the proactive, guideline-driven administration of pneumococcal vaccination to this vulnerable population.

References

AAFP (American Academy of Family Physicians). (2006). Diagnosis and Treatment of Community-Acquired Pneumonia. American Family Physician, 73(3), 442-450.

Aggarwal, D., Gupta, A., Chander, J., & Kumar, S. (2014). Risk factors for pulmonary tuberculosis in community-acquired pneumonia. European Respiratory Journal, 43(1), 178-187.

Almirall, J., Serra-Prat, M., Bolíbar, I., & Balasso, V. (2017). Risk Factors for Community-Acquired Pneumonia in Adults: A Systematic Review of Observational Studies. Respiration, 94(3), 299-311.

Barnes, P. J., Drazen, J. M., & Rennard, S. I. (2025). Cigarette smoking decreases macrophage-dependent clearance to impact the biological effects of occupational and environmental particle exposures. Frontiers in Public Health, 13, 1558723.

Breathe Freely. (2019). Pipe Fitter Fact Sheet. Australian Institute of Occupational Hygienists.

Breathe Freely. (2021). Pipe Fitter Fact Sheet. British Occupational Hygiene Society.

Coggon, D., Inskip, H., Winter, P., & Pannett, B. (1994). Lobar pneumonia: an occupational disease in welders. The Lancet, 344(8914), 41-43.

ContagionLive. (2025). 2025 American Thoracic Society Clinical Practice Guideline Updates for the Diagnosis and Management of Community-Acquired Pneumonia.

Cummins, J., McDiarmid, M., & Borondy-Kitts, A. (2019). Global deployment of a pneumococcal vaccination program for welders. American Journal of Industrial Medicine, 62(7), 604-608.

Dequin, P. F., Meziani, F., Quenot, J. P., Kamel, T., Ricome, S., Seguin-Givelet, A.,... & CAPE COD Trial Group. (2023). Hydrocortisone in severe community-acquired pneumonia. New England Journal of Medicine, 388(21), 1931-1941.

Falk, G., & Fahey, T. (2009). C-reactive protein and community-acquired pneumonia in ambulatory care: systematic review of diagnostic accuracy studies. Family Practice, 26(1), 10-21.

Feinsilver, S. H., Fein, A. M., & Niederman, M. S. (2003). Nonresolving and slowly resolving pneumonia. Clinics in Chest Medicine, 24(3), 431-457.

Feldman, C., & Anderson, R. (2020). The role of host defence mechanisms in the pathogenesis of community-acquired pneumonia. Journal of Infection, 80(4), 365-376.

File, T. M. (2004). Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients. Clinical Infectious Diseases, 38(Supplement_4), S328-S339.

Fine, M. J., Auble, T. E., Yealy, D. M., Hanusa, B. H., Weissfeld, L. A., Singer, D. E.,... & Kapoor, W. N. (1997). A prediction rule to identify low-risk patients with community-acquired pneumonia. New England Journal of Medicine, 336(4), 243-250.

Ho, P. L., Chan, J. M., Ip, M., & Lam, W. Y. (2008). The role of C-reactive protein in the management of community-acquired pneumonia. International Journal of Antimicrobial Agents, 32(Supplement 1), S33-S37.

Hopkins Medicine. (2023). Occupational Lung Diseases. Johns Hopkins Medicine Health Library.

Hubbs, A. F., Sargent, L. M., Porter, D. W., Sriram, K., & Schulte, P. A. (2020). Welder's Anthrax. International Journal of Environmental Research and Public Health, 17(7), 2552.

IARC (International Agency for Research on Cancer). (1982). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Volume 28: The Rubber Industry. Lyon, France: IARC.

Jain, S., Self, W. H., Wunderink, R. G., Fakhran, S., Balk, R., Bramley, A. M.,... & CDC EPIC Study Team. (2015). Community-acquired pneumonia requiring hospitalization among US adults. New England Journal of Medicine, 373(5), 415-427.

Jeong, Y. J., & Lee, K. S. (2015). Pulmonary tuberculosis: up-to-date imaging and management. American Journal of Roentgenology, 204(5), 964-976.

Johansson, N., Kalin, M., Tiveljung-Lindell, A., Giske, C. G., & Hedlund, J. (2020). Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clinical Infectious Diseases, 70(1), 78-86.

Jolobe, O. M. P. (2012). Pulmonary tuberculosis in the differential diagnosis of community-acquired pneumonia. European Respiratory Journal, 40(1), 279-280.

KSK (Kemmitt, Sanford & Kramer). (2023). Common Causes of Pipefitter Injuries.

Kuru, T., & Kalkan, M. (2024). Non-resolving pneumonia in a young patient with fungal granulomatous infection: an unusual presentation of lung malignancy. Journal of Clinical and Experimental Investigations, 15(2), em00827.

Leung, C. C., Yu, I. T. S., & Chen, W. (2012). Silicosis. The Lancet, 379(9830), 2008-2018.

Lim, W. S., van der Eerden, M. M., Laing, R., Boersma, W. G., Karalus, N., Town, G. I.,... & Macfarlane, J. T. (2003). Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax, 58(5), 377-382.

Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C.,... & Infectious Diseases Society of America/American Thoracic Society. (2007). Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clinical Infectious Diseases, 44(Supplement_2), S27-S72.

Mayo Clinic. (2022). Lung cancer - Diagnosis and treatment.

Medscape. (2023). Non-Small Cell Lung Cancer (NSCLC) Clinical Presentation.

Medscape. (2024). Community-Acquired Pneumonia (CAP).

Meduri, G. U., Shih, M. C., Bridges, L., Martin, T. J., El-Solh, A., Seam, N.,... & Umberger, R. (2022). Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Medicine, 48(8), 1009-1023.

Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K.,... & Limper, A. H. (2019). Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine, 200(7), e45-e67.

Metlay, J. P., et al. (2025). Diagnosis and Management of Adults with Community-Acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline Update. American Journal of Respiratory and Critical Care Medicine.

MTP (Montana Pinnacle). (n.d.). A Physician's Guide: Plumbers and Pipefitters.

Nuorti, J. P., Butler, J. C., Farley, M. M., Harrison, L. H., McGeer, A., Kolczak, M. S., & Schuchat, A. (2000). Cigarette smoking and invasive pneumococcal disease. New England Journal of Medicine, 342(10), 681-689.

NYC DOHMH (New York City Department of Health and Mental Hygiene). (2022). Tuberculosis Clinical Policies and Protocols Manual, Chapter 3: Diagnosis of Tuberculosis.

OHSAS (Occupational Health and Safety Advisory Services). (n.d.). Welders and Pneumonia.

OSHA (Occupational Safety and Health Administration). (n.d.). Respiratory protection. 29 CFR 1910.134.

OSHA (Occupational Safety and Health Administration). (2022). Welder's Anthrax. Hazard Alert.

Palmer, K. T., & Cosgrove, M. P. (2012). Vaccinating welders against pneumonia. Occupational Medicine, 62(5), 325-330.

Palmer, K. T., Cullinan, P., Rice, S., & Brown, T. (2011). Increased mortality from infectious pneumonia after occupational exposure to inorganic dust, metal fumes and chemicals. Thorax, 66(11), 992-996.

Palmer, K. T., Poole, J., Ayres, J. G., & Coggon, D. (2003). Exposure to metal fume and infectious pneumonia. American Journal of Epidemiology, 157(3), 227-233.

Radiopaedia. (2023a). Lobar pneumonia.

Radiopaedia. (2023b). Silhouette sign (chest).

Radiology Assistant. (n.d.). Chest X-Ray - Lung Disease.

Said, M. A., Johnson, H. L., Nonyane, B. A., Deloria-Knoll, M., O'Brien, K. L., & Global, P. E. R. C. H. S. G. (2013). Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PloS one, 8(4), e60273.

Sligl, W. I., Sligl, K. A., & Marrie, T. J. (2024). Addition of Macrolide Antibiotics for Hospital Treatment of Community-Acquired Pneumonia. The Journal of Infectious Diseases.

Szram, J., Schofield, S. J., Cosgrove, M. P., & Cullinan, P. (2013). Welding, longitudinal lung function decline and chronic respiratory symptoms: a systematic review of cohort studies. European Respiratory Journal, 42(5), 1186-1193.

Szram, J., Tarrerias, A., & Coggon, D. (2005). Metal fume, host defence and pneumonia risk. European Respiratory Journal, 27(2), 366-373.

Szewczyńska, M., Pośniak, M., & Dobrzyńska, E. (2002). Identification and determination of chemical compounds in a rubber conveyor belt repair shop. International Journal of Occupational Medicine and Environmental Health, 15(4), 369-376.

Torén, K., Qvarfordt, I., Bergdahl, I. A., & Järvholm, B. (2020). Occupational exposure to fumes, dust, and gases, and risk of invasive pneumococcal disease. American Journal of Industrial Medicine, 63(3), 239-247.

Torres, A., Peetermans, W. E., Viegi, G., & Blasi, F. (2013). Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax, 68(11), 1057-1065.

van der Poll, T., & Opal, S. M. (2017). Pathogenesis, treatment, and prevention of pneumococcal pneumonia. The Lancet, 390(10103), 1643-1655.

Welte, T., Torres, A., & Nathwani, D. (2012). Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax, 67(1), 71-79.

Wergeland, E., & Iversen, B. G. (2001). Deaths from pneumonia after welding. Scandinavian Journal of Work, Environment & Health, 27(5), 353-354.

Wong, A., Marrie, T. J., Garg, S., Kellner, J. D., & Tyrrell, G. J. (2010). Welders are at increased risk for invasive pneumococcal disease. International Journal of Infectious Diseases, 14(9), e796-e799.

Downloads

Published

2025-11-01

How to Cite

Anthony Suranta Surbakti, and Agus Juanda. 2025. “Occupational Community-Acquired Pneumonia in a Fitter-Splicer With a Significant Smoking History: A Case Report and Expanded Review of the Literature”. The International Journal of Medical Science and Health Research 18 (7): 1-25. https://doi.org/10.70070/ssc4s696.